Seeyond’s United Therapeutics UTHR Stock Holding History

Seeyond’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,846	Closed	-$378K	–	631
2019 Q2	$378K	Sell	4,846 -9,126	-65%	-$853K	0.04%	477
2019 Q1	$1.64M	Buy	13,972 +11,405	+444%	+$1.33M	0.16%	215
2018 Q4	$280K	Buy	+2,567	New	+$298K	0.04%	460

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Seeyond's UTHR Position: Q3 2019 in Review

Seeyond sold out of United Therapeutics (UTHR) in Q3 2019, closing a stake of 4,846 shares — an estimated $378K sold.

Seeyond first reported a position in UTHR in Q4 2018 and held it in 3 quarters. The position peaked at $1.64M in Q1 2019. 302 funds tracked by Wall St. Rank hold UTHR as of Q3 2019.

Seeyond reported no remaining United Therapeutics position as of Q3 2019 after selling out during the quarter.
Seeyond sold 4,846 United Therapeutics shares in Q3 2019, an estimated $378K.
Seeyond first reported a position in United Therapeutics in Q4 2018 and held it in 3 quarters.
Seeyond's United Therapeutics position peaked at $1.64M in Q1 2019.
302 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2019.

Based on Seeyond's 13F filing for Q3 2019, filed 13 Nov 2019.